This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
With the right amount, timing, and quality, it can work wonders -- strengthen the immune system, improve blood sugar, even decrease the risk of heartattacks and strokes. New research seeks answers.
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heartattack and stroke among these patients, according to results from an international clinical trial led by a Mount Sinai researcher.
New research suggests older adults wait 3-6 months after a heartattack before elective noncardiac surgery to reduce the risk of serious complications like stroke or another heartattack.
A history of COVID-19 can double the risk of heartattack, stroke or death according to new research led by Cleveland Clinic and the University of Southern California.
Research Highlights: An analysis of UK Biobank health data that included adults who had mild to severe COVID-19 before vaccines were available found an increased risk of heartattack, stroke and death among those adults during the nearly three-year.
Research Highlights: An analysis of survey data for 430,000 adults in the U.S. found that using cannabis has a significant association with an increased risk of heartattack and stroke, independent of tobacco use, with higher odds among the adults.
Coronary artery calcium scoring with CT can identify symptomatic patients with a very low risk of heartattacks or strokes. Researchers said the findings may one day help some patients with stable chest pain avoid invasive coronary angiography.
Research Highlights: People who are satisfied with their lives or feel contentment or well-being may be less likely to develop heart disease and stroke than their unsatisfied counterparts. The analysis of health records for more than 120,000 adults.
Researchers found higher amounts of the sugar alcohol xylitol are associated with increased risk of cardiovascular events like heartattack and stroke. The team confirmed the association in a large-scale patient analysis, preclinical research models and a clinical intervention study.
government's premier research body has made an important discovery that could help create new drugs to lower "bad" cholesterol, and hopefully prevent heartattacks and stroke.
People who had a confirmed case of COVID-19 during the pandemic's first wave have twice the risk of heartattack, stroke and death compared to those who were never infected, according to research funded by the National Institutes of Health.
An analysis of data in the UK Biobank has found that COVID-19 infection may increase the risk of heartattack, stroke and death from any cause for up to three years for people with and without cardiovascular disease, according to new research.
Research Highlights: In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 inhibitor medication had a lower risk of a subsequent stroke, heartattack or death compared to peers who were.
Research Highlights: The risk of a heartattack among adults after a clot-caused stroke or a stroke plus a tear in the wall of a neck artery (carotid or vertebral artery dissection) was almost double within the first year compared to the heartattack.
Researchers show that genetic traits influence the cellular composition of atherosclerotic plaques, which over time will affect the risk of such lesions to cause a stroke or heartattack. The new knowledge can be used to improve the risk assessment and treatment of patients with atherosclerosis in the future.
University of Virginia School of Medicine researchers have created an "atlas of atherosclerosis" that reveals, at the level of individual cells, critical processes responsible for forming the harmful plaque buildup that causes heartattacks, strokes, and coronary artery disease.
People who are content with their lives or feel a sense of well-being may be less likely to develop heart disease and/or stroke compared to those with a lower sense of well-being, according to a new analysis published today (Sept. 18) in the Journal of the American Heart Association.
A recently unveiled cardiovascular disease risk calculator that measures a patient's risk for heartattack and stroke is better calibrated and more precise than its previous version, but if current treatment guidelines for cholesterol and blood pressure therapy remain unchanged, the new calculator may have unintended consequences, according to research (..)
MILLER, PHD, LED THE DEVELOPMENT OF A NEW "ATHEROSCLEROSIS ATLAS" THAT DETAILS, AT THE LEVEL OF INDIVIDUAL CELLS, CRITICAL PROCESSES RESPONSIBLE FOR FORMING THE HARMFUL PLAQUE BUILDUP THAT CAUSES HEARTATTACKS, STROKES AND CORONARY ARTERY DISEASE. When they break loose, they can be deadly, triggering strokes and heartattacks.
In a new study published in the European Heart Journal, researchers at Karolinska Institutet show that genetic traits influence the cellular composition of atherosclerotic plaques, which over time will affect the risk of such lesions for causing a stroke or heartattack.
Heartattack risk almost doubles in the first year after a stroke or when combined with a tear in a neck artery wall; however, a tear without a stroke does not seem to raise heartattack risk, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2024.
Research Highlights: An artificial intelligence (AI) system to help guide treatment decisions for stroke patients led to improved stroke care quality and fewer recurrent strokes, heartattacks and vascular death among stroke survivors three months.
The TACT2 study was designed to replicate the results of a previous trial, TACT , which reported in 2012 that chelation reduced subsequent cardiovascular events after a heartattack. and Canadian patients with diabetes and a history of heartattack,” said Gervasio A. and Canada.
milla1cf Sat, 04/06/2024 - 18:32 April 6, 2024 — The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heartattack or stroke within three months of a prior heartattack, according to research presented at the American College of Cardiology ’s Annual Scientific Session.
The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heartattack or stroke within three months of a prior heartattack, according to research presented at ACC.24, 24, the American College of Cardiology Annual Annual Scientific Session.
Researchers have discovered a better way of identifying those at high risk of potential heartattacks and strokes and other major cardiovascular disease (CVD) events.
Image courtesy: Getty Images christine.book Thu, 02/08/2024 - 15:53 February 8, 2024 — The latest late-breaking science from the second day of the American Stroke Association ’s International Stroke Conference , ISC 2024 , shed light on the use of artificial intelligence ( AI ) to help guide treatment decisions for stroke patients.
After a heartattack, aging adults face double or triple the risk of life-threatening complications—like a debilitating stroke or another heartattack—when they move forward with elective noncardiac surgeries too soon, according to new University of Rochester research published in JAMA Surgery.
Research Highlights: Although giving blood thinners along with clot-busting medication may help in treating heartattacks, it did not improve 90-day outcomes in people with clot-caused strokes. Enrollment in a large clinical trial, which had been.
Middle-aged adults with three or more unhealthy traits including slightly high waist circumference, blood pressure, cholesterol and glucose have heartattacks and strokes two years earlier than their peers, according to new research.
With the right amount, timing, and quality, it can work wonders—strengthen the immune system, improve blood sugar, even decrease the risk of heartattacks and strokes. New research seeks answers.
Changes to blood pressure over time could be used to identify patients at greatest risk of heartattack and stroke. These are the findings of a new analysis from the ASCOT study, led by researchers from Imperial College London and published in the European Heart Journal.
An irregular sleep-wake cycle is associated with a heightened risk of major cardiovascular events, such as heartattack and stroke, even for those who clock up the recommended nightly hours of shut-eye, finds research published online in the Journal of Epidemiology & Community Health.
Humans and mice exposed to long-wavelength red light had lower rates of blood clots that can cause heartattacks, lung damage and strokes, according to research led by University of Pittsburgh School of Medicine and UPMC surgeon-scientists and published today in the Journal of Thrombosis and Haemostasis.
Researchers have identified a new target to treat atherosclerosis, a condition where plaque clogs arteries and causes major cardiac issues, including stroke and heartattack.
Researchers from the Johns Hopkins Bloomberg School of Public Health have developed a single universal risk prediction model for cardiovascular disease that, in initial tests, works well for patients who already have cardiovascular disease as well as patients who do not but who may be at risk for developing it.
Blockage of arterial blood vessels caused by atherosclerosis is largely responsible for heartattacks and strokes, which are the most common causes of death worldwide. The complex mechanisms that lead to pathological changes in the arteries are not yet fully understood.
The risks of heartattack and stroke have decreased significantly, while complications in more peripheral vessels have increased in relative importance, according to studies at the University of Gothenburg. There has been a redistribution in the risk of arterial disease in type 1 and 2 diabetes.
Results from the ABYSS trial surprised many at ESC 2024, finding that patients who continue beta-blocker therapy after heartattacks have better long-term outcomes than patients who stop taking the drugs, and they don’t experience the quality of life downsides that some might expect. vs. 2.5%), and stroke (1% vs. 1%).
New research shows that women who hit menopause later in life have healthier blood vessels and mitochondria and a different composition of metabolites in their blood than those who stop menstruating earlier. The study helps explain why late-onset menopause is linked to lower risk of heartattacks and strokes.
An international study led by Monash University researchers has found a surprising connection between constipation and an increased risk of major adverse cardiac events (MACE), including heartattacks, strokes and heart failure.
Research Highlights: The CLEAR SYNERGY trial found that spironolactone may reduce the risk of new or worsening heart failure; however, it did not significantly impact the rate of death, new heartattack or stroke. More research is needed to further.
milla1cf Thu, 06/20/2024 - 19:40 June 20, 2024 — A programing algorithm, being tested by HonorHealth Research Institute for those patients with new or recently installed pacemakers, is designed so the device not only provides a steady heartbeat, but also controls high blood pressure. You just turn it on, and it works,” Dr.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content